Aldosterone Induces Kidney Fibroblast Proliferation via Activation of Growth Factor Receptors and PI3K/MAPK Signalling

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Nephron Experimental Nephrology

• Publication date

  2012-07-18

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1159/000339500PMID 22814207
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The selective mineralocorticoid receptor antagonist eplerenone is protective in mild anti-GBM glomeru-lonephritis.

  2011cited by this paper
• Effect of eplerenone on hypertension-associated renal damage in rats: potential role of peroxisome proliferator activated receptor gamma (PPAR-γ).

  2011cited by this paper
• Antibody blockade of c-fms suppresses the progression of inflammation and injury in early diabetic nephropathy in obese db/db mice

  2009cited by this paper
• Direct Aldosterone Action as a Profibrotic Factor via ROS-Mediated SGK1 in Peritoneal Fibroblasts

  2009cited by this paper
• Aldosterone-induced mesangial cell proliferation is mediated by EGF receptor transactivation.

  2009cited by this paper
• Aldosterone and TGF-beta1 synergistically increase PAI-1 and decrease matrix degradation in rat renal mesangial and fibroblast cells.

  2008cited by this paper
• Osteopontin in Rat Renal Fibroblasts: Functional Properties and Transcriptional Regulation by Aldosterone

  2008cited by this paper
• Effect of eplerenone, enalapril and their combination treatment on diabetic nephropathy in type II diabetic rats.

  2008cited by this paper
• Aldosterone and Angiotensin II Synergistically Stimulate Migration in Vascular Smooth Muscle Cells Through c-Src–Regulated Redox-Sensitive RhoA Pathways

  2008cited by this paper
• Aldosterone induces epithelial-mesenchymal transition via ROS of mitochondrial origin.

  2007cited by this paper
• Mineralocorticoid receptor antagonist reduces renal injury in rodent models of types 1 and 2 diabetes mellitus.

  2006cited by this paper
• Deletion of the PDGFR-β Gene Affects Key Fibroblast Functions Important for Wound Healing*

  2005cited by this paper
• Local Renal Aldosterone System and Its Regulation by Salt, Diabetes, and Angiotensin II Type 1 Receptor

  2005cited by this paper
• Aldosterone Stimulates Collagen Gene Expression and Synthesis Via Activation of ERK1/2 in Rat Renal Fibroblasts

  2005cited by this paper
• Intracellular Cyclic Nucleotide Analogues Inhibit in vitro Mitogenesis and Activation of Fibroblasts Derived from Obstructed Rat Kidneys

  2004cited by this paper
• Aldosterone in chronic kidney and cardiac disease.

  2003cited by this paper
• P2Y receptor-mediated stimulation of Müller glial cell DNA synthesis: dependence on EGF and PDGF receptor transactivation.

  2003cited by this paper
• Differential contribution of three mitogen-activated protein kinases to PDGF-BB-induced mesangial cell proliferation and gene expression.

  2003cited by this paper
• Aldosterone stimulates proliferation of cardiac fibroblasts by activating Ki-RasA and MAPK1/2 signaling.

  2003cited by this paper
• Aldosterone and d-Glucose Stimulate the Proliferation of Human Cardiac Myofibroblasts In Vitro

  2002cited by this paper
• Rapid actions of aldosterone on cells from renal epithelium: the possible role of EGF-receptor signaling.

  2002cited by this paper
• Receptor Heterodimerization: Essential Mechanism for Platelet-Derived Growth Factor-Induced Epidermal Growth Factor Receptor Transactivation

  2001cited by this paper
• TGF-beta 1 induces proliferation in human renal fibroblasts via induction of basic fibroblast growth factor (FGF-2).

  2001cited by this paper
• Cyclin kinase inhibitor p21CIP1/WAF1 limits interstitial cell proliferation following ureteric obstruction.

  1999cited by this paper
• Identification of an acid-activated Cl(-) channel from human skeletal muscles.

  1999cited by this paper
• Myofibroblasts and the progression of diabetic nephropathy.

  1997cited by this paper
• The FASEB Journal • Research Communication Imatinib mesylate blocks a non-Smad TGF- � pathway and reduces renal fibrogenesis in vivo

  year unknowncited by this paper

• Causal Relationships Between Mineralocorticoid Receptor Activation and Tubulointerstitial Nephritis and Lipid Metabolism Dysregulation: A Mendelian Randomization Study.

  2025cites this paper
• ANXA2 regulates mitochondrial function and cellular senescence of PDLCs via AKT/eNOS signaling pathway under high glucose conditions

  2025cites this paper
• Progress in the treatment of vascular complications in type 2 diabetes by finerenone in combination with RAS inhibitors/SGLT-2i.

  2025cites this paper
• Aldosterone in Chronic Kidney Disease

  2025cites this paper
• Fibrosis in Chronic Kidney Disease: Pathophysiology and Therapeutic Targets

  2024cites this paper
• Clinical implications of mineralocorticoid receptor overactivation

  2024cites this paper
• Possible mechanisms of SARS-CoV-2-associated myocardial fibrosis: reflections in the post-pandemic era

  2024cites this paper
• MINERALOCORTICOID RECEPTORS, MACROPHAGES AND NEW MECHANISMS FOR CARDIOVASCULAR DISEASE.

  2024cites this paper
• The role of perirenal adipose tissue deposition in chronic kidney disease progression: Mechanisms and therapeutic implications.

  2024cites this paper
• Promising therapeutic mechanism for Chinese herbal medicine in ameliorating renal fibrosis in diabetic nephropathy

  2023cites this paper
• Non-steroidal mineralocorticoid receptor antagonist finerenone ameliorates mitochondrial dysfunction via PI3K/Akt/eNOS signaling pathway in diabetic tubulopathy

  2023cites this paper
• Mineralocorticoid Receptor Antagonists for Preventing Chronic Kidney Disease Progression: Current Evidence and Future Challenges

  2023cites this paper
• miR-29c Inhibits Renal Interstitial Fibrotic Proliferative Properties through PI3K-AKT Pathway

  2022cites this paper
• Pathophysiology of Diabetic Kidney Disease

  2022cites this paper
• Finerenone, a Novel and Safer Approach toward Management of Diabetic Kidney Disease with Heart Failure

  2022cites this paper
• Nonepithelial mineralocorticoid receptor activation as a determinant of kidney disease.

  2022cites this paper
• Cerebro-Cardiovascular Risk, Target Organ Damage, and Treatment Outcomes in Primary Aldosteronism

  2022cites this paper
• Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease

  2021cites this paper
• Aldosterone Induces the Proliferation of Renal Tubular Epithelial Cells In Vivo but Not In Vitro

  2021cites this paper
• Aldosterone and the mineralocorticoid receptor in renal injury: A potential therapeutic target in feline chronic kidney disease

  2020cites this paper
• A combined CaMKII inhibition and mineralocorticoid receptor antagonism via eplerenone inhibits functional deterioration in chronic pressure overloaded mice

  2020cites this paper
• Role of mineralocorticoid receptor antagonists in kidney diseases

  2020cites this paper
• Potential Benefit of Mineralocorticoid Receptor Antagonists in Kidney Diseases

  2019cites this paper
• Mineralocorticoid receptor antagonists and kidney diseases: pathophysiological basis.

  2019cites this paper
• Role of Aldosterone in Renal Fibrosis.

  2019cites this paper
• Aldosterone promotes renal interstitial fibrosis via the AIF-1/AKT/mTOR signaling pathway

  2019cites this paper
• Cyclophilin D promotes tubular cell damage and the development of interstitial fibrosis in the obstructed kidney

  2018cites this paper
• Mineralocorticoid Receptor and Aldosterone-Related Biomarkers of End-Organ Damage in Cardiometabolic Disease

  2018cites this paper
• Aldosterone activates the oncogenic signals ERK 1 / 2 and STAT 3 via redox-regulated mechanisms † Running head : Aldosterone activates ERK 1 / 2 and Stat 3

  2017cites this paper
• Corticoids synergize with IL-1 in the induction of LCN2.

  2017cites this paper
• Aldosterone activates the oncogenic signals ERK1/2 and STAT3 via redox‐regulated mechanisms

  2017influential citation
• 30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Nongenomic effects via the mineralocorticoid receptor.

  2017cites this paper
• The JNK Signaling Pathway in Renal Fibrosis

  2017cites this paper
• Mineralocorticoid Receptor Signaling as a Therapeutic Target for Renal and Cardiac Fibrosis

  2017cites this paper
• Mineralocorticoid regulation of cell function: the role of rapid signalling and gene transcription pathways.

  2017cites this paper
• The Role of the Mineralocorticoid Receptor in Inflammation: Focus on Kidney and Vasculature

  2017cites this paper
• The role of oxidative stress in the crosstalk between leptin and mineralocorticoid receptor in the cardiac fibrosis associated with obesity

  2017cites this paper
• Dexamethasone and insulin activate serum and glucocorticoid‐inducible kinase 1 (SGK1) via different molecular mechanisms in cortical collecting duct cells

  2016influential citation
• A role for spleen tyrosine kinase in renal fibrosis in the mouse obstructed kidney.

  2016cites this paper
• University of Dundee Dexamethasone and insulin activate serum and glucocorticoid-inducible kinase 1 ( SGK 1 ) via different molecular mechanisms in cortical collecting duct cells

  2016influential citation
• Aldosterone mediates metastatic spread of renal cancer via the G protein‐coupled estrogen receptor (GPER)

  2016cites this paper
• Cardiac Tissue Injury and Remodeling Is Dependent Upon MR Regulation of Activation Pathways in Cardiac Tissue Macrophages.

  2016cites this paper
• Inhibition of local aldosterone by eplerenone reduces renal structural damage in a novel model of chronic cyclosporine A nephrotoxicity

  2015cites this paper
• Inhibiting ERK Activation with CI-1040 Leads to Compensatory Upregulation of Alternate MAPKs and Plasminogen Activator Inhibitor-1 following Subtotal Nephrectomy with No Impact on Kidney Fibrosis

  2015cites this paper
• Aldosterone induces clonal β-cell failure through glucocorticoid receptor

  2015cites this paper
• Suppression of Rapidly Progressive Mouse Glomerulonephritis with the Non-Steroidal Mineralocorticoid Receptor Antagonist BR-4628

  2015cites this paper
• Aldosterone up-regulates MMP-9 and MMP-9/NGAL expression in human neutrophils through p38, ERK1/2 and PI3K pathways.

  2015cites this paper
• Similar to Spironolactone, Oxymatrine Is Protective in Aldosterone-Induced Cardiomyocyte Injury via Inhibition of Calpain and Apoptosis-Inducing Factor Signaling

  2014cites this paper
• ASK1/p38 signaling in renal tubular epithelial cells promotes renal fibrosis in the mouse obstructed kidney.

  2014cites this paper
• Mineralocorticoid receptor signaling: crosstalk with membrane receptors and other modulators.

  2014cites this paper
• Aldosterone stimulates fibronectin synthesis in renal fibroblasts through mineralocorticoid receptor-dependent and independent mechanisms.

  2013cites this paper